254 related articles for article (PubMed ID: 26832799)
21. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
[TBL] [Abstract][Full Text] [Related]
22. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
[TBL] [Abstract][Full Text] [Related]
23. Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer.
Yamaguchi H; On J; Morita T; Suzuki T; Okada Y; Ono J; Evdokiou A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830099
[TBL] [Abstract][Full Text] [Related]
24. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
[TBL] [Abstract][Full Text] [Related]
25. Near infrared photoimmunotherapy in the treatment of disseminated peritoneal ovarian cancer.
Sato K; Hanaoka H; Watanabe R; Nakajima T; Choyke PL; Kobayashi H
Mol Cancer Ther; 2015 Jan; 14(1):141-50. PubMed ID: 25416790
[TBL] [Abstract][Full Text] [Related]
26. Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.
Cui Y; Li SB; Peng XC; Wu J; Fu GH
Dig Dis Sci; 2015 Dec; 60(12):3631-41. PubMed ID: 26173505
[TBL] [Abstract][Full Text] [Related]
27. A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model.
Ando H; Fukushima M; Eshima K; Hasui T; Shimizu T; Ishima Y; Huang CL; Wada H; Ishida T
Cancer Med; 2019 Dec; 8(17):7313-7321. PubMed ID: 31609087
[TBL] [Abstract][Full Text] [Related]
28. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice.
Imamura Y; Ishikawa S; Sato N; Karashima R; Hirashima K; Hiyoshi Y; Nagai Y; Koga Y; Hayashi N; Watanabe M; Yamada G; Baba H
Ann Surg Oncol; 2010 Feb; 17(2):643-52. PubMed ID: 20012217
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity.
Tanaka F; Tominaga K; Shiota M; Ochi M; Kuwamura H; Tanigawa T; Watanabe T; Fujiwara Y; Oshitani N; Higuchi K; Iwao H; Arakawa T
Cancer Gene Ther; 2008 Jan; 15(1):51-9. PubMed ID: 17992202
[TBL] [Abstract][Full Text] [Related]
31. Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.
Jin MH; Nam AR; Park JE; Bang JH; Bang YJ; Oh DY
Mol Cancer Ther; 2017 Jun; 16(6):1145-1154. PubMed ID: 28223426
[TBL] [Abstract][Full Text] [Related]
32. Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer.
Tsunemitsu Y; Kagawa S; Tokunaga N; Otani S; Umeoka T; Roth JA; Fang B; Tanaka N; Fujiwara T
Gut; 2004 Apr; 53(4):554-60. PubMed ID: 15016751
[TBL] [Abstract][Full Text] [Related]
33. HER2 targeting near-infrared photoimmunotherapy for a CDDP-resistant small-cell lung cancer.
Takahashi K; Taki S; Yasui H; Nishinaga Y; Isobe Y; Matsui T; Shimizu M; Koike C; Sato K
Cancer Med; 2021 Dec; 10(24):8808-8819. PubMed ID: 34729945
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer.
Nam HJ; Ching KA; Kan J; Kim HP; Han SW; Im SA; Kim TY; Christensen JG; Oh DY; Bang YJ
Mol Cancer Ther; 2012 Feb; 11(2):439-51. PubMed ID: 22135232
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models.
Chen H; Ye Q; Lv J; Ye P; Sun Y; Fan S; Su X; Gavine P; Yin X
Pathol Oncol Res; 2015 Sep; 21(4):947-55. PubMed ID: 25749810
[TBL] [Abstract][Full Text] [Related]
36. Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression.
Shi M; Yang Z; Hu M; Liu D; Hu Y; Qian L; Zhang W; Chen H; Guo L; Yu M; Song L; Ma Y; Guo N
J Immunol; 2013 Jun; 190(11):5600-8. PubMed ID: 23630346
[TBL] [Abstract][Full Text] [Related]
37. Porphyrin modified trastuzumab improves efficacy of HER2 targeted photodynamic therapy of gastric cancer.
Korsak B; Almeida GM; Rocha S; Pereira C; Mendes N; Osório H; Pereira PMR; Rodrigues JMM; Schneider RJ; Sarmento B; Tomé JPC; Oliveira C
Int J Cancer; 2017 Oct; 141(7):1478-1489. PubMed ID: 28639285
[TBL] [Abstract][Full Text] [Related]
38. Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination.
Yamaguchi T; Fushida S; Yamamoto Y; Tsukada T; Kinoshita J; Oyama K; Miyashita T; Tajima H; Ninomiya I; Munesue S; Harashima A; Harada S; Yamamoto H; Ohta T
Gastric Cancer; 2016 Oct; 19(4):1052-1065. PubMed ID: 26621525
[TBL] [Abstract][Full Text] [Related]
39. The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer.
Wang Q; Zhang X; Shen E; Gao J; Cao F; Wang X; Li Y; Tian T; Wang J; Chen Z; Wang J; Shen L
Cancer Lett; 2016 Sep; 380(1):20-30. PubMed ID: 27317872
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic adenoviral gene transfer of a glycosyltransferase for prevention of peritoneal dissemination and metastasis of gastric cancer.
Kawamura YI; Adachi Y; Curiel DT; Kawashima R; Kannagi R; Nishimoto N; Dohi T
Cancer Gene Ther; 2014 Oct; 21(10):427-33. PubMed ID: 25213663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
